Article
Inhibition of Human Coronaviruses by Piperidine-4-Carboxamides
2022-03-03
Abstract excerpt
Immunization efforts for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been successful in reducing disease severity. However, as the pandemic continues and new variants emerge, along with vaccine hesitancy, efforts are ongoing to identify antiviral agents for SARS-CoV-2 treatment. Here, we evaluated the <i>in vitro</i> activities of piperidine-4-carboxamide compound (NCGC2955) against human...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 107cf838-2973-5934-b8bc-4168252bf938
- DOI
- 10.2139/ssrn.4032380
